Wall Street Journal reports that Peggy Hamburg and Joshua Sharfstein are expected to become commissioner and deputy commissioner, respectively, of the US Food and Drug Administration. Hamburg was a health commissioner in New York City, and Sharfstein is the health chief in Baltimore. "The White House wants to position the FDA commissioner as someone who will lead the agency back to its core mission of public health, and the focus on Dr. Hamburg and Dr.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.